Seizure News and Research

Latest Seizure News and Research

Study using i2b2 could help standardize artificial coma treatment for RSE patients

Status epilepticus, a dangerous condition in which epileptic seizures follow one another for a duration of five or more minutes without the victim's regaining consciousness between them, is the second most common neurological emergency in the United States, with a recorded maximum of around 150,000-plus cases per year.

30 Jun 2018

Hormone lab tests not necessary for most teens with gynecomastia

Routine assessment by an endocrinologist and laboratory tests to measure hormone levels aren't necessary in most adolescent boys with gynecomastia, concludes a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

30 Jun 2018

FDA approves cannabis based drug for severe form of epilepsy

The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.

28 Jun 2018

Unlocked and loaded: Families confront dementia and guns

With a bullet in her gut, her voice choked with pain, Dee Hill pleaded with the 911 dispatcher for help.

25 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Researchers develop low-cost plastic sensors to monitor wide range of health conditions

An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases.

22 Jun 2018

Christiana Care Health System opens first Epilepsy Monitoring Unit in Delaware

To increase access to advanced neurological care, Christiana Care Health System has opened the first Epilepsy Monitoring Unit in the First State.

21 Jun 2018

Study opens new window into cellular events that occur in the brain during absence seizures

At first, the teacher described her six-year-old student as absentminded, a daydreamer. The boy was having difficulty paying attention in class. As the teacher watched the boy closely, she realized that he was not daydreaming. He often blanked out for a few seconds and wouldn't respond when she called his name. On occasion, he would blink a lot and his eyes would roll up.

20 Jun 2018

Biomedical engineers uncover new fundamental feature of brain oscillations

The coordination of neural activity across widespread brain networks is essential for human cognition. Researchers have long assumed that oscillations in the brain, commonly measured for research purposes, brain-computer interfacing, and clinical tests, were stationary signals that occurred independently at separate brain regions.

8 Jun 2018

FDA warns nine online networks to stop illegal marketing of unapproved opioids

The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved and misbranded versions of opioid medications, including tramadol and oxycodone.

6 Jun 2018

FDA warns companies to cease selling illegal, highly concentrated caffeine products

The U.S. Food and Drug Administration has issued warning letters to the parties responsible for liquidcaffeine.com and Dual Health Body and Mind for illegally selling certain highly concentrated caffeine products. The FDA considers these products to be a threat to public health.

6 Jun 2018

Researchers develop new prediction method for epileptic seizures

Epileptic seizures strike with little warning and nearly one third of people living with epilepsy are resistant to treatment that controls these attacks. More than 65 million people worldwide are living with epilepsy.

30 May 2018

Early-life seizures prematurely switch on key brain synapses related to autism

Early-life seizures prematurely switch on key synapses in the brain that may contribute to further neurodevelopmental delay in children with autism and other intellectual disabilities, suggests a new study from researchers at Penn Medicine published online in Cell Reports.

29 May 2018

Raising Awareness of Childhood Dementia

The Dementia Strikes Children Too campaign aims to raise awareness of childhood dementia, drive for better clinical education of this group of diseases, and put in place the systems and tools for earlier diagnosis.

18 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

Columbia University Irving Medical Center and NewYork-Presbyterian launch new Mothers Center

In time for Mother's Day, NewYork-Presbyterian and Columbia University Irving Medical Center announced the opening of the Mothers Center, a new space that will provide comprehensive, multidisciplinary care before, during and after a high-risk pregnancy, starting later this month.

10 May 2018

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements.

10 May 2018

Seizure News and Research

Latest Seizure News and Research

Study using i2b2 could help standardize artificial coma treatment for RSE patients

Hormone lab tests not necessary for most teens with gynecomastia

FDA approves cannabis based drug for severe form of epilepsy

Unlocked and loaded: Families confront dementia and guns

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Researchers develop low-cost plastic sensors to monitor wide range of health conditions

Christiana Care Health System opens first Epilepsy Monitoring Unit in Delaware

Study opens new window into cellular events that occur in the brain during absence seizures

Biomedical engineers uncover new fundamental feature of brain oscillations

FDA warns nine online networks to stop illegal marketing of unapproved opioids

FDA warns companies to cease selling illegal, highly concentrated caffeine products

Researchers develop new prediction method for epileptic seizures

Early-life seizures prematurely switch on key brain synapses related to autism

Raising Awareness of Childhood Dementia

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Columbia University Irving Medical Center and NewYork-Presbyterian launch new Mothers Center

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

Research shows possibility of new ways to address blood-brain barrier dysfunction in epilepsy

Researchers discover how key brain receptor can function in hostile environment

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Seizure News and Research

Latest Seizure News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in